Patents by Inventor John E. Burky

John E. Burky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20200157230
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: January 31, 2020
    Publication date: May 21, 2020
    Inventors: Taymar E. HARTMAN, Paul W. SAUER, John E. BURKY, Mark C. WESSON, Ping Y. HUANG, Thomas J. ROBINSON, Braeden D. PARTRIDGE, J. Yun TSO
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20180127506
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: October 4, 2017
    Publication date: May 10, 2018
    Inventors: Taymar E. HARTMAN, Paul W. SAUER, John E. BURKY, Mark C. WESSON, Ping Y. HUANG, Thomas J. ROBINSON, Braeden D. PARTRIDGE, J. Yun TSO
  • DAC HYP compositions
    Patent number: 9815903
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: November 14, 2017
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS
    Publication number: 20170247461
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: May 4, 2017
    Publication date: August 31, 2017
    Inventors: Taymar E. HARTMAN, Paul W. SAUER, John E. BURKY, Mark C. WESSON, Ping Y. HUANG, Thomas J. ROBINSON, Braeden D. PARTRIDGE, J. Yun TSO
  • DAC HYP compositions and methods
    Patent number: 9676860
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: June 13, 2017
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP compositions and methods
    Patent number: 9340619
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: May 17, 2016
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP compositions and methods
    Patent number: 9260528
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: February 16, 2016
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20150274832
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: June 9, 2015
    Publication date: October 1, 2015
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20150203583
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: January 21, 2015
    Publication date: July 23, 2015
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20150197573
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: March 27, 2015
    Publication date: July 16, 2015
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20120301429
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: May 25, 2012
    Publication date: November 29, 2012
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden Partridge, J. Yun Tso
  • Adapted NS0 cell lines with the ability to grow under glutamine-free conditions
    Publication number: 20040002135
    Abstract: The present invention provides for an adapted NS0 myeloma cell line that has the ability to grow in glutamine-deficient or glutamine-free condition. In one particular embodiment, the adapted NS0 cell line has an Accession Number ATCC No. PTA-4106.
    Type: Application
    Filed: March 10, 2003
    Publication date: January 1, 2004
    Inventors: Paul W. Sauer, John E. Burky